Chase Investment Counsel Corp Medtronic PLC Transaction History

Chase Investment Counsel Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 26, 2022	SELL	$87.4 - $113.09 $281,428 - $364,149	-3,220 Closed	0 $0
Q1 2022 Apr 21, 2022	BUY	$100.58 - $112.38 $9,052 - $10,114	90 Added 2.88%	3,220 $357,000
Q4 2021 Feb 02, 2022	BUY	$99.53 - $127.75 $311,528 - $399,857	3,130 New	3,130 $323,000
Q2 2020 Aug 05, 2020	SELL	$84.11 - $103.33 $1.28 Million - $1.57 Million	-15,225 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$72.92 - $121.3 $1.11 Million - $1.85 Million	15,225 New	15,225 $1.37 Million

2,288

1.02B

8.05M

7.19M

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $108B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

Get notified when there are updates to the investment portfolio of Chase Investment Counsel Corp, based on Form 13F filings with the SEC.

Stay updated on Chase Investment Counsel Corp with notifications on news.